Northwest Biotherapeutics In Recovery From Thursday Debacle?

By: via Benzinga
Northwest Biotherapeutics (NASDAQ: NWBO) have seen a recovery, after shares plunged when a doctor running a key clinical trial for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.